Dicofol is an organochlorine insecticide widely used to prevent pests worldwide. Consequently, serious environmental problems have arisen from the application of dicofol. Bioremediation is an effective solution for dicofol persistence in the environment. In this study, a bacterial strain D-2, identified to genus Microbacterium, capable of degrading dicofol was isolated from dicofol-contaminated agricultural soil. This represents the first dicofol degrading bacterium isolated from this genus. Microbacterium sp. D-2 degraded 50 mg/L dicofol within 24 h at a rate of 85.1%. Dicofol was dechlorinated by D-2 and the further degradation metabolite was indentified as p,p′-dichlorobenzophenone(DCBP). Soils inoculated with Microbacterium sp. D-2 degraded 81.9% of the dicofol, while soils without D-2 only degraded 20.5% of the dicofol present. This finding suggests that strain D-2 has great potential in bioremediation of dicofol-contaminated soils.
Interleukin 2 (IL-2) is an anti-cancer cytokine that stimulates T cell propagation, triggering innate and adaptive immunity. IL-2 has been used for cancer therapy and has achieved curative effects. Recombinant adenovirus p53 injection (rAd‑p53) is a gene therapeutic agent that may improve the prognosis of patients with glioblastoma (GBM). In the present study, the effect of combined IL‑2 and rAd‑p53 treatment was studied. The ability of IL‑2 to stimulate immunoregulation and the ability of p53 to induce apoptosis for GBM was researched in the GBM tumor model. In addition, the activity of IL‑2 was analyzed. The antitumor potential of IL‑2 and rAd‑p53 was studied using xenograph mice carrying GBM cells. Tumor‑specific CD4+ and CD8+ T cells were also analyzed in the GBM‑bearing models. The results demonstrated that IL‑2 and rAd‑p53 not only stimulated tumor‑specific cytotoxic T‑lymphocyte responses and increased regulatory CD4+ and cytotoxic CD8+ T cell proliferation, however additionally increased expression of apoptosis‑associated genes. The treatment with IL‑2 and rAd‑p53 resulted in tumor regression and prolonged the survival of glioma‑bearing mice. Taken together, a combination of IL‑2 and rAd‑p53 treatment combines the effects of immunotherapy and oncolytic therapy and may be a comprehensive therapeutic schedule for clinical application in future cancer therapies.
The bactrial strain Cupriavidus sp. DT-1 can degrade 3,5,6-trichloro-2-pyridinol (TCP) and transform it into 2-hydroxypyridine (2-HP). This is a unique degradation pathway of TCP but incomplete. In the present study, strain DT-1 could degrade 2-HP at a high concentration 500 mg/L and use it as sole carbon source for growth. Three metabolites (nicotine blue, maleamic acid and fumaric acid) were detected in the medium and the complete degradation pathway of TCP was derived. Inoculation of TCP-contaminated soils with strain DT-1 resulted in a degradation rate 94.4% and 86.7% as compared to 20.4% and 28.4% in uninoculated soils, respectively. Fluorescent marker gene gfp was introduced into strain DT-1 and a new strain DT-1- gfp was created, viability test showed the strain could survive well in soils for more than 35 d. This finding suggests that strain DT-1 has potential for use in bioremediation of TCP-contaminated environments.